Prefilled Syringes Market worth $14.53 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., April 1, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Prefilled Syringes Market is projected to grow from about USD 8.65 billion in 2026 to USD 14.53 billion by 2031, at a CAGR of 10.9%.

Browse 250 market data Tables and 60 Figures spread through 300 Pages and in-depth TOC on "Prefilled Syringes Market - Global Forecast to 2031"

Prefilled Syringes Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 8.65 billion
• 2031 Projected Market Size: USD 14.53 billion
• CAGR (2026–2031): 10.9%

Prefilled Syringes Market Trends & Insights:

• By design, the single-chamber prefilled syringes segment held the largest share of the market at 61.0% in 2025.
• By material, the glass syringes segment led the prefilled syringes market in 2025, capturing a share of 64.8%.
• By application, the cancer segment is expected to register the highest CAGR of 13.7% during the forecast period.
• The Asia pacific is expected to grow at the highest CAGR of 12.5% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331

The prefilled syringes market is expected to experience significant growth in the coming years due to the rising prevalence of chronic diseases, technological advancements, increasing demand for self-injection devices, and growing biologics market. However, there are several factors restraining growth in the prefilled syringes market. These may include stringent regulations, product recalls, and potential competition from alternative drug delivery methods.

By type, The conventional prefilled syringes segment accounted for the largest share of the prefilled syringes market in 2025.

The conventional prefilled syringes segment holds the largest share of the prefilled syringes market due to its widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment's dominance is driven by its versatility and the established manufacturing processes that support large-scale production to meet global healthcare demands effectively. Conventional prefilled syringes contribute a significant portion to the overall share of the prefilled syringes segment because they are widely utilized in various therapeutic applications. These syringes come prefilled with a particular dosage of medication, ensuring ease of use and accurate/precise doses for healthcare providers as well as patients. They are user-friendly, have a reduced chance of contributing to contamination, and are compatible with a variety of drugs. The versatility of this segment complements established manufacturing methods in high-scale production to ensure adequate supply to global healthcare needs.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331

By material, the glass prefilled syringes segment accounted for the largest share of the prefilled syringes market in 2025.

The glass prefilled syringes segment holds the largest share of the prefilled syringes market primarily due to its superior material properties and suitability for sensitive formulations of drugs. In general, glass syringes have some inherent advantages because they are inert; therefore, the risk of drug interaction or leaching is minimal. They are therefore ideal for biologics, vaccines, and other complex formulations. In addition, glass syringes are clear and allow the drug to be seen, allowing for accurate dosage administration. The glass syringes are less durable than plastic syringes, but improvements in glass technology have made glass syringes safer and more robust, thus reinforcing their dominance in the market.

By design, the single-chamber prefilled syringes segment accounted for the largest share of the prefilled syringes market in 2025.

The single-chamber prefilled syringes segment commands the largest share of the prefilled syringes market due to their simplicity and cheapness for drug delivery. These syringes come prefilled with a single compartment containing a specific medication, thus rendering them simple to fabricate and operate. For ease of handling and diminished risk of medication errors, these types of syringes find extensive applications in a range of therapeutic areas—from vaccine delivery to insulin administration.

By application, the cancer segment accounted for the largest share of the prefilled syringes market in 2025.

The cancer segment holds the largest share of the prefilled syringes market owing to the increasing prevalence and the rising demand for precise and targeted drug delivery systems. Among the significant advantages of prefilled syringes in oncology treatments are accurate dosing, reduced risk of contamination, and superior patient compliance. They can be used for the delivery of chemotherapeutics, monoclonal antibodies, and supportive care drugs, thus enabling tailored approaches to therapy and better patient outcomes. This segment's performance alludes to the indispensable contribution of prefilled syringes to advanced cancer treatments and continued innovations aimed at addressing specific oncological conditions.

In 2025, North America accounted for the largest share of the prefilled syringes market.

The prefilled syringes market is segmented into six major regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East & Africa, and the GCC Countries.

North America holds the largest share of the prefilled syringes market due to an advanced healthcare infrastructure, an impressively high adoption of advanced medical technologies, and extensive investments in drug development and research. The North American position is beneficially supported by strict regulatory standards that endorse the use of prefilled syringes for effective and safe drug delivery. In addition, with an increase in chronic diseases, the demand for prefilled syringes in North America is rising. Further, the presence of numerous pharmaceutical companies and biotechnology firms enhances the growth of the market.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=16618331

Top Companies in Prefilled Syringes Market:

The Top Companies in Prefilled Syringes Market include BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Medical International Co., Ltd. (China), Credence MedSystems, Inc. (US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), Sharps Technology, Inc. (US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co., Ltd. (Japan), Shandong Province Medicinal Glass Co., Ltd. (China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD. (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Fill Finish Manufacturing Market - Global Forecast to 2030

Pharmaceutical Drug Delivery Market - Global Forecast to 2029

Diabetes Care Devices Market - Global Forecast to 2030       

Cancer Biomarkers Market - Global Forecast to 2029

Vaccines Market - Global Forecast to 2030

About MarketsandMarkets™ 

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg